key: cord-0737190-kcjc05u9 authors: Cui, Xiaojian; Zhao, Zhihu; Zhang, Tongqiang; Guo, Wei; Guo, Wenwei; Zheng, Jiafeng; Zhang, Jiayi; Dong, Cuicui; Na, Ren; Zheng, Lisheng; Li, Wenliang; Liu, Zihui; Ma, Jia; Wang, Jinhu; He, Sijia; Xu, Yongsheng; Si, Ping; Shen, Yongming; Cai, Chunquan title: A systematic review and meta‐analysis of children with Coronavirus Disease 2019 (COVID‐19) date: 2020-08-06 journal: J Med Virol DOI: 10.1002/jmv.26398 sha: 1698c199367fe2c5f0d6a1be4ebb47dc0bd27c1e doc_id: 737190 cord_uid: kcjc05u9 OBJECTIVE: To provide a comprehensive and systematic analysis of demographic characteristics, clinical symptoms, laboratory findings and imaging features of coronavirus disease 2019 (COVID‐19) in pediatric patients. METHODS: A meta‐analysis was carried out to identify studies on COVID‐19 from December 25, 2019 to April 30, 2020. RESULTS: A total of 48 studies with 5829 pediatric patients were included. Children at all ages were at risk for COVID‐19. The main illness classification ranged as: 20% (95% CI: 14 to 26%, I(2)=91.4%) asymptomatic, 33% (95% CI: 23 to 43%, I(2)=95.6%) mild and 51% (95% CI: 42 to 61%, I(2)=93.4%) moderate. The typical clinical manifestations were fever 51% (95% CI: 45 to 57%, I(2)=78.9%) and cough 41% (95% CI: 35 to 47%, I(2)=81.0%). The common laboratory findings were normal white blood cell 69% (95% CI: 64 to 75%, I(2)=58.5%), lymphopenia 16% (95% CI: 11 to 21%, I(2)=76.9%) and elevated creatine‐kinase MB (CK‐MB) 37% (95% CI: 25 to 48%, I(2)=59.0%). The frequent imaging features were normal images 41% (95% CI: 30 to 52%, I(2)=93.4%) and ground‐glass opacity 36% (95% CI: 25 to 47%, I(2)=92.9%). Among children under 1‐year old, critical cases account for 14% (95% CI: 13 to 34%, I(2)=37.3%) that should be of concern. In addition, vomiting occurred in 33% (95% CI: 18 to 67%, I(2)=0.0%) cases that may also need attention. CONCLUSIONS: Pediatric patients with COVID‐19 may experience milder illness with atypical clinical manifestations and rare lymphopenia. High incidence of critical illness and vomiting symptoms reward attention in children under 1‐year old. This article is protected by copyright. All rights reserved. An outbreak of the coronavirus disease 2019 (COVID-19) is spreading rapidly around the world, which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. As of 26 July 2020, the COVID-19 pandemic has resulted in approximate 15,785,641 confirmed cases, including 640,016 deaths worldwide 1 This study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and was registered in PROSPERO as CRD42020191099. To identify studies pertaining clinical, laboratory and imaging features in children with COVID-19, we systematically searched from PubMed, Web of Science, Chinese Wanfang and China National Knowledge Infrastructure (CNKI) databases for relevant articles published through April 30, 2020. Moreover, additional records identified from World Health Organization (WHO)/Center for Disease Control (CDC) reports, medRxiv, bioRxiv SSRN and Google Scholar. We also reviewed the references of all identified articles to identify additional studies. Search terms were as follows: novel coronavirus, nCoV, SARS2 vaccine, Wuhan coronavirus vaccine, 2019 novel coronavirus, novel coronavirus 2019, 2019 nCoV, COVID-19, Wuhan coronavirus, Wuhan pneumonia and SARS-CoV-2. These terms were used in combination with "AND" or "OR". The literature review was performed independently by two investigators (XJC and TQZ), with a third reviewer (YMS) resolving any disputes as needed. We included published papers (cohort studies, case series and case reports) that given available data about the demographic information, clinical, laboratory, and image features in children with COVID-19. Pediatric population were defined as under 18 years old. SARS-CoV-2 nucleic acid was teased by RT-PCR in accordance with the WHO guideline 9 . The level of laboratory test items was determined according to the following standards: normal white blood cell: 5.5-12.0×10 9 /L, leukocytosis: >12.0×10 9 /L, leukopenia: <5.5×10 9 /L, lymphopenia: <1.2×10 9 /L, high PCT: >0.046 ng/ml, high CRP: >10 mg/L, high LDH: >300 U/L, high ALT: >45 U/L, high AST: >50 U/L, high Creatinine: >62μmol/L, high Blood urea nitrogen: >7.1 mmol/L, high CK: >170 U/L, high CK-MB: >25 U/L, high D-dimer: >0.55 mg/L. We excluded studies that did not report original data or clear diagnostic criteria, and no relevant outcome. Two authors (XJC and TQZ) independently extracted relevant information, including first author, publication year, sex (male, %), country, number of COVID-19 patients, age distribution (ratio of <1 year, 1-5 years, 6-10 years, This article is protected by copyright. All rights reserved. week, with hypoxia performance, and dyspnea occurs, oxygen saturation is less than 0.92; Critical: Children may rapidly progress to acute respiratory distress syndrome (ARDS) or respiratory failure. They may also develop shock, coagulation dysfunction or other multiple organ dysfunction, which may endanger their lives. Moreover, we extracted clinical performance data including fever, cough, sore throat, tachycardia, rhinorrhea, nasal congestion, tachypnea, diarrhea, vomiting, myalgia or fatigue, hypoxemia and chest pain. Clinical laboratory results were extracted based on blood routine tests, liver function tests, renal function measurement, cardiac function, inflammatory factors and D-dimer. Distributions for all imaging: This article is protected by copyright. All rights reserved. normal, ground-glass opacity (GGO), local patchy shadowing, bilateral patchy shadowing, white lung change and pleural effusion. We used the quality assessment tool for case series studies published by the National Institutes of Health (NIH) to assess the methodological quality of included studies 11 . We scored 0 or 1 point for each item according to the criteria and added scores for all items to generate an overall quality score that ranged from 0 to 8. Based on the overall score, we classified studies as low (≥7), moderate (5-6), or high risk of bias (≤4). Any disagreement was resolved through discussion by all investigators. We performed data analysis using metan packages in STATA (version 12.0, Stata Corp., College Station, TX). Statistical heterogeneity between studies was evaluated with Cochran's Q test and the I 2 statistic. The I 2 -value less than 50% was equivalent to no heterogeneity, whereas values greater than 50% was equivalent to large heterogeneity among studies. Freeman-Tukey double arcsine transformation was used to stabilize the variance of specific prevalence rates between the included studies 12 . To account for the potential heterogeneity of studied population in each study reflected by different geographic locations, ethnicity, age group, and so forth, a randomeffect model using the DerSimonian and Laird method was used to aggregate effect sizes to estimate the overall pooled prevalence and corresponding 95% CIs. To explore the reasons for heterogeneity, subgroup analyses were applied based on the study type (non-case reports versus case reports). The Begg's funnel plot was performed to evaluate the This article is protected by copyright. All rights reserved. Accepted Article publication bias. P value less than 0.05 was identified as statistically significant. Table 1 . One study was from Singapore, one from Korea, one from Spain, one from America and one from Iranian. The rest studies were all from China. The number of patients ranged from 1 to 2490, and male patients ranged from 0 to 1408. Twenty-nine studies were case reports, sixteen studies were case series, and the rest three studies were cohort studies. Total scores of the included studies ranged from 3 to 8 and mean scores was 5.69. The percentage scores were used for ordinal categorization of the studies as low quality (≤4, 25%), medium quality (5-6, 43.8%) and high quality (≥7, 31.2%). The detailed results on quality assessment were listed in supplementary material 1 (S1). Among all the children cases, 17% (95% CI: 15 to 18%, I 2 =48.6%) was under 1 year old at diagnosis, 24% (95% CI: 19 to 29%, I 2 =80.6%) 1 to 5 years old, 25% (95% CI: 19 to 31%, I 2 =88.7%) 6 to 10 years old, 20% (95% CI: 16 to 24%, I 2 =82.7%) 11 to 15 years old and 18% (95% CI: 8 to 28%, I 2 =96.7%) were 15 years old or more. Gender was shown as the proportion of males (M). Male gender of the children with COVID-19 was 55% (95%CI: 53 to 58%, I 2 =33.4%, P=0.030). The proportion of cases with known contact history was estimated at 72% (95% CI: 64 to 80%, I 2 =90.1%, P=0.000). were divided in six groups as indicated based on disease severity from light to severe, mainly including: asymptomatic, mild, moderate, severe, critical and death. Included patients were classified by their clinicians as asymptomatic 20% (95% CI: 14 to 26%, I 2 =91.4%), mildly 33% (95% CI: 23 to 43%, I 2 =95.6%), moderate 51% (95% CI: 42 to 61%, I 2 =93.4%), severely 7% (95% CI: 4 to 11%, I 2 =90.2%), critically 5% (95% CI: 2 to 9%, I 2 =84.5%), and death 0% (95% CI: 0 to 0%, I 2 =94.9%). Among children under 1 year old cases, asymptomatic 6% (95% CI: 5 to 13%, I 2 =24.3%), mildly 54% (95% CI: 49 to 59%, I 2 =0.0%), moderate 36% (95% CI: 27 to 45%, I 2 =4.0%), severely 7% (95% CI: 4 to 11%, I 2 =34.3%), and critically 14% (95% CI: 13 to 34%, I 2 =37.3%).( Table 2 The most common clinical manifestations were fever 51% (95% CI: 45 to 57%, I 2 =78.9%), cough 41% (95% CI: 35 to 47%, I 2 =81.0%), sore throat 16% (95% CI: 7to 25%, I 2 =91.6%), tachycardia 12% (95% CI: 3 to 21%, I 2 =93.9%), rhinorrhea 14% (95% CI: 8 to 19%, I 2 =75.4%), nasal congestion 17% (95% CI: 6 to 27%, I 2 =87.2%), tachypnea 9% (95% CI: 4 to 14%, I 2 =87.4%), diarrhea 8% (95% CI: 6 to 11%, I 2 =47.0%), vomiting 7% (95% CI: 5 to 10%, I 2 =50.4%), myalgia or fatigue 12% (95% CI: 7 to 17%, I 2 =77.7%), hypoxemia 3% (95% CI: 1 to 4%, I 2 =0.0%) and chest pain 3% (95% CI: 0 to 5%, I 2 =0.0%). Among children under 1 year old cases, fever 53% (95% CI: 30 to 76%, I 2 =0.0%), cough 30% (95% CI: 2 to 58%, I 2 =0.0%), rhinorrhea 21% (95% CI: 5 to 43%, I 2 =0.0%), nasal congestion 50% (95% CI: 20 to 99%, I 2 =0.0%), tachypnea 33% (95% CI: 20 to 57%, I 2 =0.0%) and vomiting 33% (95% CI: 18 to 67%, I 2 =0.0%).( Table 2) Laboratory examination Laboratory examination results, which including blood routine test, liver function tests, renal function measurement, cardiac function, inflammatory factors and D-dimer, were shown in Fig. 5 . With respect to laboratory findings, the proportion of normal white blood cell in COVID-19 patients in children was 69% (95% CI: 64 to 75%, I 2 =58.5%). Leukocytosis (>12×10 9 /L) was observed in 10% (95% CI: 7 to 14%, I 2 =63.1%) of patients, and 19% (95% CI: 14 to 25%, I 2 =80.9%) patient had leukopenia (<5.5×10 9 /L). The proportion of patients with lymphopenia was 16% (95% CI: 11 to 21%, I 2 =76.9%). The proportion of patients with high PCT 36% (95% CI: 21 to 51%, I 2 =97.0%), CRP 19% (95% CI: 13 to 26%, I 2 =79.3%) and LDH 29% (95% CI: 20 to 39%, I 2 =69.8%), respectively. ALT and AST are indicative parameters for liver function, the high ALT and AST patients was 11% (95% CI: 7 to 15%, I 2 =38.5%) and 18% (95% CI: 13 to 23%, I 2 =48.6%), respectively. CK and CK-MB are indicative parameters for cardiac function, the high CK and CK-MB was 9% (95% CI: 1 to 17%, I 2 =33.2%) and 37% (95% CI: 25 to 48%, I 2 =59.0%), respectively. We also evaluated the patients had elevated D-dimer, result revealed that nearly 11% (95% CI: 8 to 14%, Among children under 1-year old cases, the proportion of lymphopenia was 33% (95% CI: 24 to 47%, I 2 =0.0%). The ratio of elevated CRP and LDH were 42% (95% CI: 6 to 78%, I 2 =0.0%) and 50% (95% CI: 15 to 69%, I 2 =0.0%), respectively. The high ALT and AST patients were 47% (95% CI: 25 to 69%, I 2 =0.0%) and 33% (95% CI: 20 to 67%, I 2 =0.0%), respectively. The proportion of elevated CK-MB was 88% (95% CI: 71 to 94%, I 2 =8.5%). Imaging features for patients were summarized in Fig. 6 . All pediatric patients with normal imaging was 41% (95% CI: 30 to 52%, I 2 =93.4%), GGO 36% (95% CI: 25 to 47%, I 2 =92.9%), local patchy shadowing 26% (95% CI: 21 to 32%, I 2 =58.2%), bilateral patchy shadowing 28% (95% CI: 21 to 35%, I 2 =73.8%), white lung change was 2% (95% CI: 0 to 4%, I 2 =0.0%) and pleural effusion 2% (95% CI: 0 to 3%, I 2 =0.0%). This article is protected by copyright. All rights reserved. Among children under 1-year old cases, the proportion of normal imaging was 42% (95% CI: 6 to 78%, I 2 =0.0%). The GGO accounted for 50% (95% CI: 20 to 80%, I 2 =0.0%) of lung abnormality. Local and bilateral patchy shadowing were 42% (95% CI: 6 to 78%, I 2 =0.0%) and 40% (95% CI: 13 to 55%, I 2 =0.0%), respectively. ( Table 2) Publication bias Table 2) . The main findings are as follows: First, SARS-CoV-2 was susceptible to all age groups of children, the most common clinical manifestations were fever and cough and the majority of them had experienced asymptomatic, mild and moderate illness; Second, children were more likely to have normal leukocyte counts, whereas lymphocytosis occurred infrequently; Third, the incidence of critical illness and vomiting symptoms were high in children under 1 year old. The pandemic of COVID-19 affected all age-groups in children based on the current studies 3,6,60 . Our result was consistent with those previous studies that there was no significant difference in age distribution of SARS-CoV-2 infection among children. The most common clinical manifestations of COVID-19 pediatric patients were fever (51%) and cough (41%) from our meta-analysis, which were lower than the fever (78.0-92.8%) and cough (57.0-63.4%) in adults 4,5,61 . These findings further suggested that children's clinical symptoms were not typical when compared with adults. The frequency of severe illness was 7% in children with COVID-19, which was lower than that in adults (25.6%) 5 . One possible reason might be that children are less likely to have underlying diseases such as diabetes, hypertention or cardiovascular disease. In addition to the above reason, the fact that innate immune response declines with age could also be important for the difference 62 . The percentage of asymptomatic in children with COVID-19 was 20% and deserves full attention to control the ongoing pandemic. For the laboratory examination, normal leukocyte counts was up to 70% in children, which was as similar as 69.7% in adults 63 . The reduction of lymphocytes in children was only 16%, but in adults it went up to 43.1% 4 , 57.4% 5 and 56% 63 respectively reported by previously meta-analysis. The reason for these differences may be related to the immune response of different organisms to novel coronavirus. The level of CK-MB was raising in 37% of all children, which is one of classical biomarkers of cardiotoxicity. Subgroup analysis further revealed CK-MB was elevated in nearly 88% in children under 1-year old. These results suggested that we should pay special attention to the myocardial damage in children, especially for those under 1-year old. It should be noted that the activity of CK-MB was detected by immunosuppressive method, which is easy to be affected by the peripheral blood creatine kinase BB (CK-BB). In addition, the blood-brain barrier in children, especially in infants, is not fully developed, and more CK-BB will appear in the peripheral blood, resulting in the high level of CK-MB activity [64] [65] [66] . In the future, specific studies are still needed to explain the causes and effects of CK-MB elevation in children. The CT manifestations of COVID-19 in pediatric patients are diverse and lack specificity depending on the severity of disease or clinical classification. Normal imaging occurred in 41% pediatric patients in our meta-analysis, which are similar to the other two reports with the largest number of pediatric cases so far, the proportion of normal lung CT was 35% (60/171) and 57% (66/115) respectively 13,58 , but, it was infrequent in adults, the rate of normal imaging was only 10% 67 . GGO was the most common performance in children presenting lung abnormality, which most located in the lower lung, outer band, near the pleura and the scope was small compared with adults 13, 15, 17, 29, 35, 68, 69 . Pediatric patients with GGO was 36%, significantly lower than adults with 80-83% 5,67 . This may be related to the fact that COVID-19 in children shows milder than adults. This article is protected by copyright. All rights reserved. The rate of critical illness in children under 1 year old was 14%, higher than 5% in all children. These results suggested that clinicians should pay more attention to changes in disease activity in children under 1 year old. A total of 33% and 7% suffer from vomiting in children under 1 year old and all children respectively. Based on all the above facts, it was worth noting that the proportion of infants developing critical cases is relatively high, and the initial symptom often include vomiting. However, due to the limited sample size, large, well-designed studies are still needed to confirm these findings. This meta-analysis has several limitations that should be addressed. The COVID-19 pandemic affects all age-groups in children and appears to be mild illness. The common presenting complaints with COVID- Fig. 1 Flow diagram for the included studies. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved. WHO Coronavirus Disease (COVID-19 Epidemiology of COVID-19 Among Children in 13 Clinical features of children with SARS-CoV-2 infection: an analysis of 115 cases Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features The different clinical characteristics of corona virus disease cases between children and their families in China-the character of children with COVID-19 Clinical features and chest CT findings of coronavirus disease 2019 in infants and young children Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China Detection of Covid-19 in Children in Early Clinical features of pediatric patients 37 Clinical characteristics of a case series of children with coronavirus disease 2019 Clinical and epidemiological features of 36 children China: an observational cohort study The clinical and epidemiological features and hints of 82 confirmed COVID-19 pediatric cases aged 0-16 in Wuhan Clinical and epidemiological characteristics of 91 children conformed with COVID-19 A single-center, retrospective study of COVID-19 features in children: a descriptive investigation Epidemiological and Clinical Characteristics of 74 Children Infected with SARS-CoV-2 in Family Clusters in Wuhan Symptomatic Infection is Associated with Prolonged Duration of Viral Shedding in Mild Coronavirus Disease 2019: A Retrospective Study of 110 Children in Wuhan A retrospective study of the clinical characteristics of COVID-19 infection in 26 children Clinical Characteristics of Children with Coronavirus Disease Novel coronavirus infection in children outside of Wuhan, China Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study COVID-19 infection in Iranian children: a case series of 9 patients Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children Clinical features of children with SARS-CoV-2 infection: an analysis of 13 cases from Changsha Epidemiological and clinical characteristics of 10 children with coronavirus disease ( COVID-19) in Jinan City Clinical characteristics of novel coronavirus pneumonia in children in Jinan Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding Clinical analysis of 1 novel coronavirus infecting pneumonia cases in Yunnan Frist case of severe childhood novel coronavirus pneumonia in China SARS-CoV-2 infection in children Coronavirus Disease 2019 in Children -United States COVID-19 in children and altered inflammatory responses The prevalence of symptoms in 24 COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries Evolution of the immune system in humans from infancy to old age Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis Diagnostic value of Myocardial troponin I,CK-MB and C reactive protein in children with viral myocarditis The difference between the normal value of serum creatine kinase MB in children and that in adults Clinical evaluation of serum creatine phosphokinase isoenzyme in healthy children at different ages CT Findings: A Systematic Review and Meta-analysis CT features of novel coronavirus pneumonia (COVID-19) in children High resolution CT features of novel coronavirus pneu monia in children Ji